- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
QTI
NASDAQ
Week ended 31 Jul 2026
Weekly Investor Report
QT Imaging Holdings, Inc. Common Stock · Healthcare · Medical Devices
Latest close
2.69 USD
-2.9%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is - below the Trend Line and sits at 1.0% of its 52-week range. The latest completed week returned -2.9%, after a -33.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal; earnings are due in 4d.
Setup score
22
out of 100
Latest Close
2.69 USD
31 Jul 2026
1W Return
-2.9%
latest completed week
4W Return
-33.6%
short-term follow-through
12W Return
-61.7%
quarterly tape
Trend Breadth
0.0%
0 of 27 weeks active
Volume Ratio
0.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 40.52% based on similar historical setup states.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.9%
Latest completed week; four-week move -33.6%.
Indicator stack
0/50
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 40.52%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
56/100
62 relevant articles in the latest sentiment read.
Event risk
4d
Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is - below the Trend Line and sits at 1.0% of its 52-week range. The latest completed week returned -2.9%, after a -33.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.15
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -33.6% over four weeks, -61.7% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 73%
Model confidence 70%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength42/100Blend of value, momentum, and quality. Underlying universe rank 59; rank 1 is best.
Value46/100Relative valuation strength. Underlying universe rank 55; rank 1 is best.
Quality45/100Profitability and accounting quality. Underlying universe rank 56; rank 1 is best.
Momentum46/100Medium-term price momentum. Underlying universe rank 55; rank 1 is best.
Growth46/100Revenue and earnings growth. Underlying universe rank 55; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 1.7x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -24.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 41.7% Gross profit retained from each unit of revenue.
- Operating margin
- -46.2% Operating profit retained from revenue.
- Free-cash-flow margin
- -39.4% Free cash flow generated from revenue.
- Return on invested capital
- -296.2% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 258.8% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -46.1% Net share repurchases relative to market value.
- Shareholder yield
- -46.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment56/100
Weighted news tone is neutral across 62 relevant articles.
14 positive · 44 neutral · 4 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-64.6%Distance below the 52-week high.
13-week volatility10.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher10 of 2615 weeks finished lower.
Best week+15.9%Week of 20 Mar.
Worst week-23.2%Week of 5 Jun.
Latest week-2.9%Week of 31 Jul.
Shape of recent returns
Strong gains8
Modest gains2
Flat weeks1
Modest losses5
Sharp losses10
Recent vol10.0%13-week weekly-return volatility.
Base vol9.8%52-week weekly-return volatility.
Up/down split10/15Count of positive and negative weeks in the 52-week window.
Average skew7.2% / -8.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average-1.5%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD78.0%positive activity pressure
RS49.0%positive relative leadership
Four-week leaders
IndustryUS Medical Devices
4-week rank99 / 100
Group average-2.3%
Trend breadth36.0%
Trend36.0%active weekly trend signals
MD67.0%positive activity pressure
RS29.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape25/100
Trend, activity pressure, participation, and risk combine to a 25/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 40.52%Next-week expectancy is negative with a 40.52% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors44/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 96 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment56/100Weighted news tone is neutral across 62 relevant articles.
QTI|QT Imaging Holdings Inc|Price:2.770|Chg%:-0.030 Insiders50/100No recent insider transaction evidence is stored.
Earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 2.69 USD | -2.9% | - | 5.22 USD | 0.00 | - | 133.1K | Off |
| 24 Jul 2026 | 2.77 USD | -15.5% | - | 5.32 USD | 0.00 | - | 475.1K | Off |
| 17 Jul 2026 | 3.28 USD | -10.6% | - | 5.42 USD | 0.00 | - | 118.6K | Off |
| 10 Jul 2026 | 3.67 USD | -9.4% | - | 5.51 USD | 0.00 | - | 66.2K | Off |
| 3 Jul 2026 | 4.05 USD | -0.5% | - | 5.59 USD | 0.00 | - | 113.8K | Off |
| 26 Jun 2026 | 4.07 USD | 10.0% | - | 5.66 USD | 0.00 | - | 195.4K | Off |
| 19 Jun 2026 | 3.70 USD | -8.4% | - | 5.74 USD | 0.00 | - | 195.4K | Off |
| 12 Jun 2026 | 4.04 USD | 5.2% | - | 5.84 USD | 0.00 | - | 210.6K | Off |
| 5 Jun 2026 | 3.84 USD | -23.2% | - | 5.93 USD | 0.00 | - | 427.7K | Off |
| 29 May 2026 | 5.00 USD | -0.6% | - | 6.05 USD | 0.00 | - | 134.8K | Off |
| 22 May 2026 | 5.03 USD | -7.7% | - | 6.11 USD | 0.00 | - | 359.7K | Off |
| 15 May 2026 | 5.45 USD | -22.4% | - | 6.18 USD | 0.00 | - | 826.7K | Off |
| 8 May 2026 | 7.02 USD | 6.0% | - | 6.23 USD | 0.00 | - | 286.9K | Off |
| 1 May 2026 | 6.62 USD | 2.4% | - | 6.17 USD | 0.00 | - | 94.1K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.